No Data
No Data
No Data
Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $21
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating
Express News | B of A Securities Maintains Underperform on Integra Lifesciences, Lowers Price Target to $18
Integra LifeSciences Upgraded to Neutral From Sell at BTIG
BTIG Upgrades Integra Lifesciences(IART.US) to Hold Rating, Maintains Target Price $20
No Data
No Data
Money Mover OP : $Medtronic (MDT.US)$ $Intuitive Surgical (ISRG.US)$